ABVC BioPharma, Inc. (ABVC)
NASDAQ: ABVC · IEX Real-Time Price · USD
0.713
-0.022 (-2.99%)
At close: Jun 21, 2024, 4:00 PM
0.706
-0.007 (-0.97%)
After-hours: Jun 21, 2024, 5:08 PM EDT

ABVC BioPharma Revenue

ABVC BioPharma had revenue of $25.36K in the twelve months ending March 31, 2024, down -97.63% year-over-year. Revenue in the quarter ending March 31, 2024 was $1.21K, a -99.06% decrease year-over-year. In the year 2023, ABVC BioPharma had annual revenue of $152.43K, a decrease of -84.28%.

Revenue (ttm)
$25.36K
Revenue Growth
-97.63%
P/S Ratio
305.06
Revenue / Employee
$1,585
Employees
16
Market Cap
7.74M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023152.43K-817.35K-84.28%
Dec 31, 2022969.78K613.99K172.57%
Dec 31, 2021355.80K-127.25K-26.34%
Dec 31, 2020483.05K-218.67K-31.16%
Dec 31, 2019701.72K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Molecular Templates 31.76M
Precipio 15.81M
Vivos Therapeutics 13.36M
Genetic Technologies 5.78M
NeuroMetrix 5.27M
Kineta 5.16M
PAVmed 3.02M
Fresh2 Group 2.35M
Revenue Rankings